IPO Guru
Bajaj
Listed Mainboard

Alkem Laboratories IPO Subscription Status

Alkem Laboratories IPO was subscribed 44.29 times when bidding closed on 10 Dec 2015: QIB 57.19x, NII 129.96x, Retail 3.17x.

The Alkem Laboratories IPO has been subscribed 44.29x times overall. Retail investors have shown interest with bids for 3.17x the shares available. The Non-Institutional Investor (NII) category has been subscribed 129.96x. Qualified Institutional Buyers (QIBs) have subscribed 57.19x. Data last updated on 12 Nov, 03:10 PM.

The IPO subscription period has ended. Given the strong demand, the allotment process is expected to be highly competitive. The issue opened on 08 Dec, 2015 and closes on 10 Dec, 2015. The shares are expected to list on stock exchanges on 23 Dec, 2015.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Live bidding

Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.

Last updated 12 Nov 2026, 03:10 PM
Category Bid details Times
QIB - of - - 57.19x
NII - of - - 129.96x
Retail - of - - 3.17x
Employee - of - - 0.67x
TOTAL - - 44.29x
Advertisement

Alkem Laboratories IPO allotment probability

Your odds of an allotment in each category at the current subscription.

Retail (up to ₹2 L)
1 out of 3
~31.5% chance per PAN — based on 3.17x subscription. Winners get exactly 1 lot (₹14,700) by SEBI lottery, however many lots you bid.
NII / HNI (above ₹2 L)
1 out of 130
~0.8% chance — lottery allots the minimum application per winner (SEBI NII rule since 2022).
QIB (institutions)
57.19x
Proportionate allotment — at 57.19x, institutions receive ~1.7% of their bid. No lottery; not open to individual investors. Strong institutional endorsement.

Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.

Subscription insights

What the current book is saying, read off the category numbers above.

Retail Allotment

Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 31.5% for a single lot.

Institutional Backing

Massive institutional interest with QIBs subscribing 57.19x. This often signals long-term confidence from professional funds.

Day-wise subscription history

End-of-day subscription across the 1-day bidding window. On phones, tap a day for the category split.

Date Total
10 Dec 2015
Day 1
44.29x ▼
QIB57.19x BHNI- SHNI- Retail3.17x Employee0.67x

Alkem Laboratories IPO dates

From the bidding window to listing. Today is 15 November.

Key dates Listed
  1. Open 08 Dec 2015
  2. Close 10 Dec 2015
  3. Allotment 15 Dec 2015
  4. Refund/credit TBA
  5. Listing 23 Dec 2015

Anchor investor allocation

Shares allotted to anchor investors the working day before the issue opened.

Anchor Investor Amt (₹ cr.) % Allocated
MORGAN STANLEY MAURITIUS COMPANY LIMITED ₹32.05 Cr 8.10%
ICICI PRUDENTIAL TOP 100 FUND ₹30.03 Cr 7.59%
ABU DHABI INVESTMENT AUTHORITY - BEHAVE ₹20.02 Cr 5.06%
DSP BLACKROCK MUTUAL FUND - DSP BLACKROCK SMALL & MID CAP FUND ₹20.02 Cr 5.06%
APAX GLOBAL ALPHA LIMITED ₹20.02 Cr 5.06%
ICICI PRUDENTIAL LIFE INSURANCE COMPANY LTD ₹20.02 Cr 5.06%
CHENNAI 2007, C/O HARVARD MANAGEMENT CO INC ₹20.00 Cr 5.06%
HDFC TRUSTEE COMPANY LIMITED - HDFC PRUDENCE FUND ₹19.99 Cr 5.06%
D.B. INTERNATIONAL (ASIA) LTD ₹15.03 Cr 3.80%
FRANKLIN TEMPLETON MUTUAL FUND A/C TEMPLETON PRIMA FUND ₹15.02 Cr 3.80%
HDFC STANDARD LIFE INSURANCE COMPANY LTD. ₹15.02 Cr 3.80%
RELIANCE CAPITAL TRUSTEE CO. LTD- A/C RELIANCE PHARMA FUND ₹14.33 Cr 3.62%
UTI - LONG TERM EQUITY FUND (TAX SAVING) ₹12.35 Cr 3.12%
KUWAIT INVESTMENT AUTHORITY A/C KUWAIT INVESTMENT AUTH FD 225 ₹10.02 Cr 2.53%
GRANDEUR PEAK INTERNATIONAL OPPORTUNITIES FUND ₹10.02 Cr 2.53%
PARVEST EQUITY INDIA ₹10.02 Cr 2.53%
KOTAK MAHINDRA (UK) LTD A/C INDIA BLUECHIP (MAURITIUS) LTD ₹10.02 Cr 2.53%
RELIANCE CAPITAL TRUSTEE CO LTD -A/C- RELIANCE REGULAR SAVINGS FUND -EQUITY OPTION ₹10.00 Cr 2.53%
KOTAK EMERGING EQUITY SCHME ₹9.42 Cr 2.38%
TEMPLETON INDIA EQUITY INCOME FUND ₹7.51 Cr 1.90%
FRANKLIN TEMPLETON MUTUAL FUND A/C TEMPLETON INDIA GROWTH FUND ₹7.51 Cr 1.90%
HDFC TRUSTEE CO LTD PREMIER MULTICAP FUND ₹5.02 Cr 1.27%
HDFC TRUSTEE CO. LTD. A/C HDFC SMALL AND MID CAP FUND ₹5.02 Cr 1.27%
TATA BALANCED FUND ₹5.02 Cr 1.27%
AXIS MUTUAL FUND TRUSTEE LIMITED A/CAXIS MUTUAL FUND A/C AXIS SMALL CAP FUND ₹5.02 Cr 1.27%
SBI PHARMA FUND ₹4.00 Cr 1.01%
SBI MAGNUM MULTIPLIER FUND ₹4.00 Cr 1.01%
IDFC CLASSIC EQUITY FUND ₹3.52 Cr 0.89%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE INDIA GENNEXT FUND ₹3.25 Cr 0.82%
RELIANCE CAPITAL TRUSTEE CO LTD-A/C RELIANCE EQUITY SAVINGS FUND ₹3.20 Cr 0.81%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 1 ₹2.73 Cr 0.69%
KOTAK MIDCAP ₹2.60 Cr 0.66%
RELIANCE CAPITAL TRUSTEE CO LTD-A/C- RELIANCE RETIREMENT FUND - WEALTH CREATION SCHEME ₹2.50 Cr 0.63%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 3 ₹2.47 Cr 0.63%
SBI MAGNUM MULTICAP FUND ₹2.10 Cr 0.53%
SBI EQUITY OPPORTUNITIES FUND - SERIES II ₹2.00 Cr 0.51%
SBI EQUITY OPPORTUNITIES FUND - SERIES IV ₹2.00 Cr 0.51%
UTI - PHARMA & HEALTHCARE FUND ₹1.86 Cr 0.47%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUNLIFE ADVANTAGE FUND ₹1.63 Cr 0.41%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C INDIA ADVANTAGE (OFFSHORE) FUND ₹1.63 Cr 0.41%
IDFC MONTHLY INCOME PLAN ₹1.53 Cr 0.39%
KOTAK MAHINDRA BALANCE UNIT SCHEME 99 ₹1.50 Cr 0.38%
BIRLA SUNLIFE TRUSTEE COMPANY PRIVATE LIMITED A/C BIRLA SUN LIFE EMERGING LEADERS FUND - SERIES 4 ₹1.30 Cr 0.33%
SBI MAGNUM MONTHLY INCOME PLAN FLOATER ₹0.90 Cr 0.23%
KOTAK EQUITY SAVING SCHEME ₹0.90 Cr 0.23%
INDIA PHARMA FUND UNIT SCHEME OPTION A ₹0.80 Cr 0.20%
KOTAK CLASSIC EQUITY ₹0.60 Cr 0.15%
TOTAL ₹395.52 Cr 100.00%
View allotment letter PDF →

What does this subscription data mean?

IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:

  • 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
  • 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
  • 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
  • 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.

Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.

Frequently asked

What is the current subscription status of Alkem Laboratories IPO?

As of IPO close date (10 Dec, 2015), the Alkem Laboratories IPO is subscribed 44.29x times. Retail category is 3.17x, and NII is 129.96x subscribed.

When is the allotment date for Alkem Laboratories IPO?

The allotment for Alkem Laboratories IPO is expected to be finalized on 15 December, 2015.

When will Alkem Laboratories IPO list on the stock market?

Alkem Laboratories is scheduled to list on BSE and NSE on 23 December, 2015.

What are the chances of getting allotment in Alkem Laboratories IPO?

The retail category is oversubscribed at 3.17x, meaning allotment is by lottery. Statistically, approximately 1 in 4 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.

What does QIB subscription of 57.19x mean for Alkem Laboratories IPO?

Strong — QIBs (mutual funds, FIIs, insurance companies) have subscribed 57.19x, indicating high institutional conviction. Heavy QIB demand is historically one of the strongest predictors of a positive listing.

How to check Alkem Laboratories IPO allotment status?

After the allotment date (15 Dec, 2015), you can check your Alkem Laboratories IPO allotment status on IPO Guru's allotment checker, on the BSE/NSE website using your PAN or application number, or through your broker's app.

Explore Alkem Laboratories IPO further

Track every stage of this IPO, from subscription to listing.

IPO Guru App
IPO Guru on Android

Subscription moves by the hour. Get it on your phone.

Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.

Get it on Google Play Join the WhatsApp channel

Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.

Total
44.29x
QIB
57.19x
NII
129.96x
Retail
3.17x
Full IPO details
Advertisement